Randomized placebo-controlled trial of emricasan for non-alcoholic steatohepatitis-related cirrhosis with severe portal hypertension - Garcia-Tsao, G; Bosch, J; Kayali, Z; IDN-6556-14 Investigators(‡) (J Hepatol, 2020)